Location:
A concise analysis of Ubigene’s gene editing advantages—including the CRISPR-U system, library screening platform, cell bank, AI-driven automation, and end-to-end services—to accelerate research and drug development.
Learn the key steps of gene knock-in cell line generation—from CRISPR/Cas9 design and HDR to donor construction, optimization, and single-clone validation.
Discover how exosomal PIK3CA mutations activate fibroblasts, reshape the tumor microenvironment, and promote colorectal cancer metastasis, supported by Ubigene.
Learn how to choose the right CRISPR library (KO, CRISPRi, CRISPRa) for high-throughput gene function screens. Ubigene offers end-to-end custom library services.
HuH7 cell line has become widely utilized in studies of liver disease pathogenesis, HCV/HBV replication biology, drug discovery, and tumor research.